Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) announced today that the U.S. Food and Drug Administration (FDA) has approved once-daily YOSPRALA™ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE